Overview
Mark Bellingham practices in Australia. Mr. Bellingham is rated as a Distinguished expert by MediFind in the treatment of Glutamate Decarboxylase Deficiency. His top areas of expertise are Glutamate Decarboxylase Deficiency, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Ataxia-Telangiectasia.
His clinical research consists of co-authoring 44 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Glutamate Decarboxylase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Glutamate Decarboxylase DeficiencyMr. Bellingham isDistinguished. Learn about Glutamate Decarboxylase Deficiency.
- Advanced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Primary Lateral SclerosisMr. Bellingham isAdvanced. Learn about Primary Lateral Sclerosis.
- Experienced
- Ataxia-TelangiectasiaMr. Bellingham isExperienced. Learn about Ataxia-Telangiectasia.
- TelangiectasiaMr. Bellingham isExperienced. Learn about Telangiectasia.